Literature DB >> 35511217

Bioavailability of phosphorus and kidney function in the Jackson Heart Study.

Chi N Duong1, Oladimeji J Akinlawon1, Joseph Gung2, Sabrina E Noel1, Sherman Bigornia3, Kaylea Flanagan1, Shirin Pourafshar4, Pao-Hwa Lin5, Clemontina A Davenport5,6, Jane Pendergast5,6, Julia J Scialla4,5, Katherine L Tucker1.   

Abstract

BACKGROUND: High phosphorus (P) exposure may have negative effects on kidney function. Nutrient databases provide total P, but bioavailability varies by source.
OBJECTIVES: We aimed to assess natural, added, and bioavailable P intake, and to relate these to estimated glomerular filtration rate (eGFR) in the Jackson Heart Study (JHS).
METHODS: A total of 3962 African-American participants of the JHS, aged 21-84 y, with urine albumin:creatinine ratio < 30 mg/g, and eGFR ≥ 60 mL · min-1 · 1.73 m-2, and without self-reported kidney disease, were included. Diet was assessed by FFQ. We assigned P in foods as naturally occurring or added, and weighted intake by P bioavailability, based on published literature. Relations between P variables and eGFR were assessed using multivariable regression.
RESULTS: Mean ± SE intakes were 1178 ± 6.7 mg and 1168 ± 5.0 mg for total P, 296 ± 2.8 mg and 291 ± 2.1 mg for bioavailable added P, and 444 ± 2.9 mg and 443 ± 2.2 mg for bioavailable natural P, in participants with eGFR = 60-89 and ≥90 mL · min-1 · 1.73 m-2, respectively. Major sources of total P included fish, milk, beef, eggs, cheese, and poultry; and of added P, fish, beef, processed meat, soft drinks, and poultry. After adjustment for confounders, P intakes, including total (β ± SE: -0.32 ± 0.15; P = 0.03), added (β ± SE: -0.73 ± 0.27; P = 0.01), bioavailable total (β ± SE: -0.62 ± 0.23; P = 0.01), and bioavailable added (β ± SE: -0.77 ± 0.29; P = 0.01), were significantly associated with lower eGFR. However, neither total nor bioavailable P from natural sources were associated with eGFR.
CONCLUSIONS: Added, but not natural, P was negatively associated with kidney function, raising concern about P additives in the food supply. Further studies are needed to improve estimation of dietary P exposure and to clarify the role of added P as a risk factor for kidney disease.
© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.

Entities:  

Keywords:  African Americans; Jackson Heart Study; bioavailability; diet; kidney function; nutrition; phosphorus intake

Mesh:

Substances:

Year:  2022        PMID: 35511217      PMCID: PMC9348986          DOI: 10.1093/ajcn/nqac116

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   8.472


  54 in total

Review 1.  Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

Authors:  Julia J Scialla; Myles Wolf
Journal:  Nat Rev Nephrol       Date:  2014-04-01       Impact factor: 28.314

Review 2.  Dietary Phosphorus Intake and the Kidney.

Authors:  Alex R Chang; Cheryl Anderson
Journal:  Annu Rev Nutr       Date:  2017-06-14       Impact factor: 11.848

3.  FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy.

Authors:  Sigrid Lundberg; Abdul Rashid Qureshi; Sara Olivecrona; Iva Gunnarsson; Stefan H Jacobson; Tobias E Larsson
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 8.237

Review 4.  Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?

Authors:  Marijn Speeckaert; Wim Van Biesen; Joris Delanghe; Robbert Slingerland; Andrej Wiecek; James Heaf; Christiane Drechsler; Raluca Lacatus; Raymond Vanholder; Ionut Nistor
Journal:  Nephrol Dial Transplant       Date:  2014-01-26       Impact factor: 5.992

5.  The Impact of Additives on the Phosphorus, Potassium, and Sodium Content of Commonly Consumed Meat, Poultry, and Fish Products Among Patients With Chronic Kidney Disease.

Authors:  Arti Sharma Parpia; Mary L'Abbé; Marc Goldstein; Joanne Arcand; Bernadene Magnuson; Pauline B Darling
Journal:  J Ren Nutr       Date:  2017-11-14       Impact factor: 3.655

6.  Organic and inorganic dietary phosphorus and its management in chronic kidney disease.

Authors:  Nazanin Noori; John J Sims; Joel D Kopple; Anuja Shah; Sara Colman; Christian S Shinaberger; Rachelle Bross; Rajnish Mehrotra; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Iran J Kidney Dis       Date:  2010-04       Impact factor: 0.892

7.  Variation in intakes of calcium, phosphorus, magnesium, iron and potassium in 10 countries in the European Prospective Investigation into Cancer and Nutrition study.

Authors:  A A Welch; H Fransen; M Jenab; M C Boutron-Ruault; R Tumino; C Agnoli; U Ericson; I Johansson; P Ferrari; D Engeset; E Lund; M Lentjes; T Key; M Touvier; M Niravong; N Larrañaga; L Rodríguez; M C Ocké; P H M Peeters; A Tjønneland; L Bjerregaard; E Vasilopoulou; V Dilis; J Linseisen; U Nöthlings; E Riboli; N Slimani; S Bingham
Journal:  Eur J Clin Nutr       Date:  2009-11       Impact factor: 4.016

8.  The prevalence of phosphorus-containing food additives in top-selling foods in grocery stores.

Authors:  Janeen B León; Catherine M Sullivan; Ashwini R Sehgal
Journal:  J Ren Nutr       Date:  2013-02-08       Impact factor: 3.655

9.  High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III.

Authors:  Alex R Chang; Mariana Lazo; Lawrence J Appel; Orlando M Gutiérrez; Morgan E Grams
Journal:  Am J Clin Nutr       Date:  2013-11-13       Impact factor: 7.045

10.  Not all forms of dietary phosphorus are equal: an evaluation of postprandial phosphorus concentrations in the plasma of the cat.

Authors:  Jennifer C Coltherd; Ruth Staunton; Alison Colyer; Gäelle Thomas; Matthew Gilham; Darren W Logan; Richard Butterwick; Phillip Watson
Journal:  Br J Nutr       Date:  2018-11-13       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.